spacer
home > ebr > winter 2002 > the splice of life
PUBLICATIONS
European Biopharmaceutical Review

The Splice of Life

Converting knowledge derived from genomics into therapeutics was never going to be straightforward. Simply knowing the number and sequence of genes in the human genome is not enough. Instead, researchers need to understand the functions of the huge diversity of proteins produced by this genetic code, as proteins are responsible for most cellular activities and form the majority of drug targets.

This is one reason for the huge growth in proteomics research, as researchers try to elucidate cellular events at the level of proteins. However, proteomics requires studies on a far greater scale than genomics. This is due to the vast number of different proteins produced by post-translational modifications, polyadenylation (1) and, perhaps most importantly, the way in which RNA is processed.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Fabien Schweighoffer PhD, Executive Vice-President of Therapeutic Programs at ExonHit Therapeutics Dr Fabien Schweighoffer is one of the founders of ExonHit Therapeutics. Previous to this he was employed as a Research Scientist in the Molecular Biology department of Rhфne-Poulenc Rorer (now Aventis) for 10 years.
Fabien holds a PhD in Biochemistry from the University of Paris, has published many papers and received several awards..

spacer
Dr Fabien Schweighoffer
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Entry now open for the PPMA Group Industry Awards 2019

The 2019 PPMA Group Industry Awards will be held at the National Conference Centre (NEC), Birmingham, on the evening of the first day of the PPMA Total Show 2019 – Tuesday, 1 October 2019. 
More info >>

White Papers

Clinical Trial Labelling – More Than Just Labels

Faubel & Co. Nachfolger GmbH

Deciding which label is best for a particular trial project is not always easy. Labels have become multifunctional tools which are able to convey variable data in different languages, indicate first opening, product originality, support ease of use or blind study drugs. They are no longer used as mere carriers of specified contents.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement